RE:RE:The duty of Loyalty for a CEOI applaude your positivity, however how many times over the years have you heard Inmed investors say:
"There are good things happening"
"Now is a great time to buy"
"See you at fifty"
Blah, blah, blah.....
Doesn't matter what is happening at Inmed - Adams can't execute anything. We've witnessed it for years. He failed. It's time to bring someone in who can push the ball down the field and actually get things done in a timely manner.
As for bringing products to market, Shane Johnson (Baymedica) said that the sales staff consists of him, that's it, no one else. So, even if they are able to bring something to market, they will have to develop a sales plan and hire sales and management for it. God knows, this could take Adams a year to do - or longer. Who knows.
And as far as cannabinoid manufacturing, you missed my point. Adams said all along that Integrasyn would be able to produce pharma grade AND consumer grade faster, cheaper and more efficiently than anyone else. Now all of the sudden that's not the case? Sounds fishy to me.
The whole point is the market (and big investors) will continue to shrug at any news from Inmed because the track record shows deep failures and lack of transparency from management. If you bring in a new CEO who delivers on goals and does what they say they are going to do, then Inmed will see a massive sp increase.
The days of low energy, kick the can, "don't question me just leave me alone" Eric Adams are over. Plain and simple.